Always seek advice from your trial team or pharmacist before travelling with an IMP
Nausea is the most frequently reported gastrointestinal side effect of GLP-1 receptor agonists, with vomiting occurring less commonly but still affecting a significant proportion of users
However, anyone who experiences intense pain, heavy bleeding, or other unusual symptoms should contact a healthcare provider
Details in syringe units explained
This connection activates G-proteins, increasing cyclic Adenosine Monophosphate (cAMP) levels (Campbell and Drucker 2013)
For users choosing to stay at lower doses, the peptide cost calculator can help quantify the savings of maintaining at 1.0 mg versus escalating to 2.4 mg, since lower doses mean fewer milligrams consumed per month and longer vial life